A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery

NCT07570940 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Atrial Fibrillation

Interventions

DRUG: Liposomal bupivacaine
DRUG: Placebo

Sponsor

Mayo Clinic